(Q40173073)

18 September 2017

In vitro activities of the new antifungal drug eberconazole and three other topical agents against 200 strains of dermatophytes (English)

1 reference

18 September 2017

3

1 reference

18 September 2017

Belkys Fernández-Torres

series ordinal

1

1 reference

18 September 2017

Isabel Inza

series ordinal

2

1 reference

18 September 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

Journal of Clinical Microbiology

18 September 2017

1 reference

18 September 2017

41

1 reference

18 September 2017

11

1 reference

18 September 2017

5209-5211

1 reference

Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes.

18 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=262513

Use of the sensititre colorimetric microdilution panel for antifungal susceptibility testing of dermatophytes.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=262513

22 September 2017

Six novel antimycotics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=262513

In vitro activities of 10 antifungal drugs against 508 dermatophyte strains

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=262513

A double-blind randomized comparative trial: eberconazole 1% cream versus clotrimazole 1% cream twice daily in Candida and dermatophyte skin infections

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=262513

Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty-first century

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=262513

Terbinafine. An update of its use in superficial mycoses

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=262513

In vitro susceptibilities of clinical yeast isolates to the new antifungal eberconazole compared with their susceptibilities to clotrimazole and ketoconazole

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=262513

Onychomycosis--treatment, relapse and re-infection

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=262513

In vitro susceptibility of dermatophytes to antifungal drugs: a comparison of two methods.

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=262513

Topical treatment with eberconazole of the experimental guinea pig cutaneous candidosis

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=262513

Clinical comparison of the efficacy and tolerability of once daily Canesten with twice daily Nizoral (clotrimazole 1% cream vs. ketoconazole 2% cream) during a 28-day topical treatment of interdigital tinea pedis

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=262513

Comparison of two methods for antifungal susceptibility testing of Trichophyton rubrum

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=262513

The use of systemic antimycotics in dermatotherapy

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=262513

Topical treatment of tinea corporis and tinea cruris with eberconazole (WAS 2160) cream 1% and 2%: a phase II dose-finding pilot study

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=262513

[Use of topical antifungal agents in Spain]

20 August 2018

1 reference

12 December 2020

Comparative study between terbinafine 1% emulsion-gel versus ketoconazole 2% cream in tinea cruris and tinea corporis

1 reference

12 December 2020

Recurrent tinea pedis: a double blind study on the prophylactic use of fenticonazole powder

1 reference

12 December 2020

Efficacy and tolerability of terbinafine 1% topical solution used for 1 week compared with 4 weeks clotrimazole 1% topical solution in the treatment of interdigital tinea pedis: a randomized, double-blind, multi-centre, 8-week clinical trial

1 reference

12 December 2020

10.1128/JCM.41.11.5209-5211.2003

Identifiers

DOI

1 reference

18 September 2017

1 reference

18 September 2017

PubMed publication ID

14605165

1 reference